BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Gritstone Oncology

Gritstone Oncology logo

Founded
2015
Geography
United States of America based
Funding
$216 M

Gritstone Oncology is a cancer immunotherapy company developing next-generation personalized cancer therapeutics. Gritstone brings together distinguished scientific founders, an experienced and diverse management team, a seasoned and successful board of directors, and very deep financial backing to tackle fundamental challenges at the intersection of cancer biology, immunology, and immunotherapy design. The company’s initial goal is to identify and deploy therapeutic neo-antigens from individual patients’ tumors to develop novel treatments for lung cancer.

Technologies

AI Companies (Drug Discovery)  

R&D Platform


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet